{"doi":"10.1093/infdis/jiaf504","title":"Pharmacokinetics and Safety of Clofazimine in Women With Rifampicin-resistant Tuberculosis During Pregnancy and the Postpartum Period: Results From IMPAACT P1026s","abstract":"BACKGROUND: There are no published data on clofazimine pharmacokinetics during pregnancy, and safety data are limited. We present data from pregnant and postpartum women receiving clofazimine for treatment of rifampicin-resistant tuberculosis (RR-TB). METHODS: IMPAACT P1026s was an observational study to assess the pharmacokinetics of tuberculosis and/or antiretroviral drugs during pregnancy. Between 2017 and 2019, pregnant women receiving ≥2 second-line antituberculosis drugs in routine care were enrolled in the second or third trimester and had intensive pharmacokinetic sampling at least once during pregnancy, and 2-8 weeks postpartum. Pharmacokinetic parameters were estimated using noncompartmental methods and compared between the antepartum and postpartum periods using geometric mean ratios (GMR) with 90% confidence intervals (CIs) and the Wilcoxon signed rank test for paired data. RESULTS: Eleven pregnant women from South Africa, 7 (64%) with HIV, were receiving clofazimine (100 mg daily) at enrollment, of which 82% received clofazimine for more than 8 weeks prior to pharmacokinetic evaluation. Nine (82%) women continued treatment postpartum. Peak plasma concentrations and area-under-the-concentration-time-curve over 12 hours were comparable to historical clofazimine pharmacokinetic data in nonpregnant women with RR-TB but were approximately 30% higher in the third trimester of pregnancy compared to the postpartum period. Eight women and 8 infants experienced at least one severe adverse event while on study but direct relatedness to clofazimine was considered unlikely. CONCLUSIONS: Overall, antepartum and postpartum clofazimine exposures were comparable to those reported in nonpregnant women with RR-TB. Exposures were lower than expected in the postpartum period, particularly compared with the third trimester of pregnancy.","journal":"The Journal of Infectious Diseases","year":2025,"id":527373,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":3,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9013,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2025-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1404686,"name":"Flynn McMorrow","orcid":null,"position":1,"is_corresponding":false},{"id":414477,"name":"Kristina M. Brooks","orcid":"0000-0002-3832-8699","position":2,"is_corresponding":false},{"id":474421,"name":"Mauricio Pinilla","orcid":null,"position":3,"is_corresponding":false},{"id":473780,"name":"Lee Fairlie","orcid":"0000-0001-5327-1734","position":4,"is_corresponding":false},{"id":376443,"name":"James S. Ngocho","orcid":"0000-0001-6242-9863","position":5,"is_corresponding":false},{"id":400926,"name":"Alice Stek","orcid":null,"position":6,"is_corresponding":false},{"id":21588,"name":"Brookie M. Best","orcid":"0000-0001-8569-2293","position":7,"is_corresponding":false},{"id":354235,"name":"Mark Mirochnick","orcid":"0000-0002-3600-1502","position":8,"is_corresponding":false},{"id":308898,"name":"Lubbe Wiesner","orcid":"0000-0002-9070-8699","position":9,"is_corresponding":false},{"id":444697,"name":"Kathleen George","orcid":null,"position":10,"is_corresponding":false},{"id":327309,"name":"Kevin Knowles","orcid":null,"position":11,"is_corresponding":false},{"id":377553,"name":"Renee Browning","orcid":null,"position":12,"is_corresponding":false},{"id":1404687,"name":"Tara DeYampert","orcid":null,"position":13,"is_corresponding":false},{"id":231911,"name":"Anneke C. Hesseling","orcid":"0000-0001-9399-9834","position":14,"is_corresponding":false},{"id":261696,"name":"Eric Decloedt","orcid":"0000-0003-1815-5150","position":15,"is_corresponding":false},{"id":194219,"name":"David E. Shapiro","orcid":null,"position":16,"is_corresponding":false},{"id":354230,"name":"Ahizechukwu C. Eke","orcid":"0000-0002-0070-9840","position":17,"is_corresponding":false},{"id":1404688,"name":"for the IMPAACT P1026s Protocol Team","orcid":null,"position":18,"is_corresponding":false},{"id":407222,"name":"Francesca Aweeka","orcid":"0000-0002-6005-6124","position":19,"is_corresponding":false},{"id":346912,"name":"Emily Barr","orcid":"0000-0002-3578-3389","position":20,"is_corresponding":false},{"id":354231,"name":"Adrie Bekker","orcid":"0000-0003-3836-3432","position":21,"is_corresponding":false},{"id":1404689,"name":"Alexander Benns","orcid":null,"position":22,"is_corresponding":false},{"id":443829,"name":"Sandra Burchett","orcid":"0000-0002-7106-9262","position":23,"is_corresponding":false},{"id":330622,"name":"Edmund V. Capparelli","orcid":"0000-0002-1630-0505","position":24,"is_corresponding":false},{"id":273033,"name":"Nahida Chakhtoura","orcid":null,"position":25,"is_corresponding":false},{"id":1404690,"name":"Nantasak Chotivanich","orcid":null,"position":26,"is_corresponding":false},{"id":377557,"name":"Diane Costello","orcid":null,"position":27,"is_corresponding":false},{"id":354236,"name":"Tim R. Cressey","orcid":"0000-0002-8106-0974","position":28,"is_corresponding":false},{"id":1404691,"name":"Lisa M Frenkeland","orcid":null,"position":29,"is_corresponding":false},{"id":667995,"name":"Anthony J. Garcia‐Prats","orcid":"0000-0002-9280-1950","position":30,"is_corresponding":false},{"id":1404692,"name":"Amy Gonzalez","orcid":null,"position":31,"is_corresponding":false},{"id":326405,"name":"Amita Gupta","orcid":"0000-0001-7036-2718","position":32,"is_corresponding":false},{"id":1404693,"name":"Adriane Hernandez","orcid":null,"position":33,"is_corresponding":false},{"id":398181,"name":"Gonzague Jourdain","orcid":"0000-0002-3365-7020","position":34,"is_corresponding":false},{"id":399650,"name":"Régis Kreitchmann","orcid":"0000-0002-1146-0497","position":35,"is_corresponding":false},{"id":247745,"name":"Pooja Mehta","orcid":"0000-0001-8466-7424","position":36,"is_corresponding":false},{"id":444698,"name":"Kittipong Rungruengthanakit","orcid":null,"position":37,"is_corresponding":false},{"id":1404694,"name":"Mary E. Smith","orcid":null,"position":38,"is_corresponding":false},{"id":1404695,"name":"Chelsea Stotz","orcid":null,"position":39,"is_corresponding":false},{"id":1044062,"name":"Pra-ornsuda Sukrakanchana","orcid":"0000-0002-3292-0499","position":40,"is_corresponding":false},{"id":328859,"name":"Marije Van Schalkwyk","orcid":"0000-0003-2679-901X","position":41,"is_corresponding":false},{"id":1187892,"name":"Jiajia Wang","orcid":"0000-0001-8559-7501","position":42,"is_corresponding":false},{"id":914632,"name":"Jennifer Hughes","orcid":"0000-0002-5349-9509","position":0,"is_corresponding":true}],"reference_count":32,"raw_metadata":null,"created_at":"2026-07-19T02:50:39.280101Z","pmid":"41165222","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}